Conventional weight loss fails for most people because it ignores the underlying hormonal and metabolic drivers of weight gain. When calorie-restricted, the body responds by increasing hunger hormones (ghrelin), reducing metabolic rate, and preserving fat stores — a perfect biological storm working against your efforts.
Weight loss peptides interrupt these mechanisms at the source. GLP-1 agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) directly suppress appetite by acting on hypothalamic receptors and slow gastric emptying — fundamentally changing hunger physiology. AOD-9604 targets beta-3 adrenergic receptors on fat cells to directly mobilize stored fat. GH secretagogues improve body composition through hormonal optimization.
Clinical trials show semaglutide produces average weight loss of 14.9% of body weight over 68 weeks — nearly 3x the efficacy of older weight loss medications. Tirzepatide trials show up to 22.5% body weight reduction. These are transformative results in medical weight management.
Our weight loss peptide programs are physician-supervised and paired with nutritional guidance, metabolic testing, and body composition monitoring. We don't just prescribe peptides — we design comprehensive programs that produce lasting results.